Overview

One-shot Ovarian Stimulation Protocol (One-shot)

Status:
RECRUITING
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The current prospective observational pilot study aims to evaluate the endocrine profile of a single-injection protocol (single CFA + daily oral administration of CC).
Phase:
NA
Details
Lead Sponsor:
Fundacin Santiago Dexeus Font
Treatments:
Clomiphene
follicle stimulating hormone, human, with HCG C-terminal peptide